Maya Perelman represents clients in all facets of commercial litigation, ranging from contract and consumer disputes to patent infringement and trade secret cases. Maya also maintains an active pro bono practice, representing indigent criminal defendants across California. Prior to joining Keker, Van Nest & Peters, Maya served as a law clerk to Judge Jesus G. Bernal of the U.S. District Court for the Central District of California.
Maya earned her J.D. from Stanford Law School and graduated from Stanford University with a B.A. in philosophy. While in law school, she worked at the San Francisco Public Defender’s Office and taught classes on substantive law and criminal procedure to incarcerated youth at the San Mateo County Youth Services Center. She also served as a course assistant in the Stanford Management Science & Engineering Department where she lectured on topics ranging from the application of Bayesian inference in criminal trials to statistical analysis of discrimination claims. She is fluent in Spanish.
We represent Genentech in a federal trade secret theft lawsuit alleging that former Genentech scientists, several of whom have also been charged criminally by the Department of Justice, stole confidential and proprietary information to help a foreign company develop biosimilar versions of Genentech medicines.
We successfully defended cloud-based telephony and unified messaging provider Dialpad in a four-patent, patent infringement action brought by an established competitor in the Northern District of California. After prevailing on an early section 101 motion, with an order that all of RingCentral’s patents and claims were unpatentable and invalid, the case resolved on highly favorable terms.
When it came to challenging a controversial felony murder bill that went into effect Jan. 1, 2019, Southern California prosecutors took a harder line than many of their counterparts in the rest of the state. But since November, when the 4th District Court of Appeal published two opinions affirming the validity of SB 1437, the state's largest local prosecutor's office has stopped disputing the bill altogether. Read more
The issues at stake in the case illustrate the growing importance of trade secrets protection to life sciences companies and the IP professionals who serve them. Read more
Genentech reaches a settlement agreement with JHL Biotech, which sees the latter cease development of biosimilars to Genentech’s products. Read more
Taiwan’s JHL Biotech has agreed to stop developing copycat versions of four Genentech biologics as part of a deal to end high-stakes trade secrets litigation. Read more